aluates Reports

$ 0.0

Automative

Global Peptide Modification Service Market Research Report 2025

Published Date: 2025-12-09

Report Code: QYRE-Auto-15U16830

Global Peptide Modification Service Market Research Report 2024

BUY CHAPTERS

Global Peptide Modification Service Market Research Report 2025

Code: QYRE-Auto-15U16830

Report

2025-12-09

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GenScript

Biosynth

Bio-Synthesis

Syd Labs

JPT

LifeTein

Creative Peptides

Elabscience

Genosphere Biotechnologies

ProSci

SB-PEPTIDE

Biomatik

Allele Life Sciences

Synpeptide

Omizzur

KMD Bioscience

Leadgene Biomedical

Boston Cellron

Bio Basic

Giotto Biotech

KenPeptide

CASLO

TGpeptide

Thermo Fisher Scientific

ProBioGen

Buchiglasuster

Peptide Modification Service Market Size

The global market for Peptide Modification Service was valued at US$ 1805 million in the year 2024 and is projected to reach a revised size of US$ 4716 million by 2031, growing at a CAGR of 14.7% during the forecast period.

Peptide Modification Service Market

Peptide Modification Service is a specialized technical service that modifies synthetic or natural peptides via chemical/biochemical means (often paired with solid-phase peptide synthesis, SPPS) to tailor their physicochemical properties, biological activity, stability, bioavailability, targeting, and detectability for research, drug development, diagnostics, and other applications. It typically includes design, synthesis, purification, characterization, and delivery of modified peptides, with customizable scales (μg–kg) and purity grades (crude to >98%).

The global market for Peptide Modification Services is a high-growth, high-value niche segment within the life sciences and pharmaceutical outsourcing industry. Driven by the surge in peptide-based therapeutics, diagnostics, and research tools, the demand for sophisticated chemical and biological modification techniques is exploding. This market is characterized by strong technical expertise, specialized infrastructure, and a focus on enabling peptide drug discovery and development. Key growth is fueled by the need to overcome the inherent limitations of native peptides (e.g., short half-life, poor stability) and the rise of novel modalities like peptide-drug conjugates (PDCs). The market is fragmented, with a mix of specialized CROs (Contract Research Organizations), CDMOs (Contract Development and Manufacturing Organizations), and a few large pharmaceutical fine chemical players.

This report aims to provide a comprehensive presentation of the global market for Peptide Modification Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Modification Service.

The Peptide Modification Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Modification Service market comprehensively. Regional market sizes, concerning products by Type, by Application, by Modification Purpose/Function and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Modification Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide Modification Service Market Report

Report Metric	Details
Report Name	Peptide Modification Service Market
Accounted market size in year	US$ 1805 million
Forecasted market size in 2031	US$ 4716 million
CAGR	14.7%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	N-Terminal Modifications C-Terminal Modifications Fluorescence Dye Labeling Phosphorylation Others
Segment by Modification Purpose/Function	Stability Optimization (amidation, cyclization, PEGylation) Targeting/Delivery (antibody conjugation, cell-penetrating peptide) Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA) PTM Mimicry (phosphorylation, glycosylation, methylation) Immunoenhancement (KLH/BSA conjugation, MAPs)
Segment by Synthesis & Process Route	Solid-phase Peptide Synthesis (SPPS)-integrated Solution-phase Synthesis Post-synthesis Modification In-situ Modification During Synthesis
Segment by Application	Commercial Academic Research
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides, Elabscience, Genosphere Biotechnologies, ProSci, Giotto Biotech, SB-PEPTIDE, Biomatik, allele life sciences, Synpeptide, Omizzur, KMD Bioscience, Leadgene Biomedical, KenPeptide, CASLO, TGpeptide, Boston Cellron, Bio Basic, ProBioGen, buchiglasuster
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Modification Purpose/Function etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Modification Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Modification Service Market growing?

Ans: The Peptide Modification Service Market witnessing a CAGR of 14.7% during the forecast period 2026-2031.

What is the Peptide Modification Service Market size in 2031?

Ans: The Peptide Modification Service Market size in 2031 will be US$ 4716 million.

Who are the main players in the Peptide Modification Service Market report?

Ans: The main players in the Peptide Modification Service Market are GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides, Elabscience, Genosphere Biotechnologies, ProSci, Giotto Biotech, SB-PEPTIDE, Biomatik, allele life sciences, Synpeptide, Omizzur, KMD Bioscience, Leadgene Biomedical, KenPeptide, CASLO, TGpeptide, Boston Cellron, Bio Basic, ProBioGen, buchiglasuster

What are the Application segmentation covered in the Peptide Modification Service Market report?

Ans: The Applications covered in the Peptide Modification Service Market report are Commercial, Academic Research

What are the Type segmentation covered in the Peptide Modification Service Market report?

Ans: The Types covered in the Peptide Modification Service Market report are N-Terminal Modifications, C-Terminal Modifications, Fluorescence Dye Labeling, Phosphorylation, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Modification Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 N-Terminal Modifications

1.2.3 C-Terminal Modifications

1.2.4 Fluorescence Dye Labeling

1.2.5 Phosphorylation

1.2.6 Others

1.3 Market by Modification Purpose/Function

1.3.1 Global Peptide Modification Service Market Size Growth Rate by Modification Purpose/Function: 2020 VS 2024 VS 2031

1.3.2 Stability Optimization (amidation, cyclization, PEGylation)

1.3.3 Targeting/Delivery (antibody conjugation, cell-penetrating peptide)

1.3.4 Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA)

1.3.5 PTM Mimicry (phosphorylation, glycosylation, methylation)

1.3.6 Immunoenhancement (KLH/BSA conjugation, MAPs)

1.4 Market by Synthesis & Process Route

1.4.1 Global Peptide Modification Service Market Size Growth Rate by Synthesis & Process Route: 2020 VS 2024 VS 2031

1.4.2 Solid-phase Peptide Synthesis (SPPS)-integrated

1.4.3 Solution-phase Synthesis

1.4.4 Post-synthesis Modification

1.4.5 In-situ Modification During Synthesis

1.5 Market by Application

1.5.1 Global Peptide Modification Service Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Commercial

1.5.3 Academic Research

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Peptide Modification Service Market Perspective (2020-2031)

2.2 Global Peptide Modification Service Growth Trends by Region

2.2.1 Global Peptide Modification Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide Modification Service Historic Market Size by Region (2020-2025)

2.2.3 Peptide Modification Service Forecasted Market Size by Region (2026-2031)

2.3 Peptide Modification Service Market Dynamics

2.3.1 Peptide Modification Service Industry Trends

2.3.2 Peptide Modification Service Market Drivers

2.3.3 Peptide Modification Service Market Challenges

2.3.4 Peptide Modification Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Modification Service Players by Revenue

3.1.1 Global Top Peptide Modification Service Players by Revenue (2020-2025)

3.1.2 Global Peptide Modification Service Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide Modification Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide Modification Service Revenue

3.4 Global Peptide Modification Service Market Concentration Ratio

3.4.1 Global Peptide Modification Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Modification Service Revenue in 2024

3.5 Global Key Players of Peptide Modification Service Head office and Area Served

3.6 Global Key Players of Peptide Modification Service, Product and Application

3.7 Global Key Players of Peptide Modification Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Modification Service Breakdown Data by Type

4.1 Global Peptide Modification Service Historic Market Size by Type (2020-2025)

4.2 Global Peptide Modification Service Forecasted Market Size by Type (2026-2031)

5 Peptide Modification Service Breakdown Data by Application

5.1 Global Peptide Modification Service Historic Market Size by Application (2020-2025)

5.2 Global Peptide Modification Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide Modification Service Market Size (2020-2031)

6.2 North America Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide Modification Service Market Size by Country (2020-2025)

6.4 North America Peptide Modification Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Modification Service Market Size (2020-2031)

7.2 Europe Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide Modification Service Market Size by Country (2020-2025)

7.4 Europe Peptide Modification Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Peptide Modification Service Market Size (2020-2031)

8.2 Asia-Pacific Peptide Modification Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide Modification Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide Modification Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Peptide Modification Service Market Size (2020-2031)

9.2 Latin America Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide Modification Service Market Size by Country (2020-2025)

9.4 Latin America Peptide Modification Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Modification Service Market Size (2020-2031)

10.2 Middle East & Africa Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide Modification Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide Modification Service Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GenScript

11.1.1 GenScript Company Details

11.1.2 GenScript Business Overview

11.1.3 GenScript Peptide Modification Service Introduction

11.1.4 GenScript Revenue in Peptide Modification Service Business (2020-2025)

11.1.5 GenScript Recent Development

11.2 Biosynth

11.2.1 Biosynth Company Details

11.2.2 Biosynth Business Overview

11.2.3 Biosynth Peptide Modification Service Introduction

11.2.4 Biosynth Revenue in Peptide Modification Service Business (2020-2025)

11.2.5 Biosynth Recent Development

11.3 Bio-Synthesis

11.3.1 Bio-Synthesis Company Details

11.3.2 Bio-Synthesis Business Overview

11.3.3 Bio-Synthesis Peptide Modification Service Introduction

11.3.4 Bio-Synthesis Revenue in Peptide Modification Service Business (2020-2025)

11.3.5 Bio-Synthesis Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Peptide Modification Service Introduction

11.4.4 Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Syd Labs

11.5.1 Syd Labs Company Details

11.5.2 Syd Labs Business Overview

11.5.3 Syd Labs Peptide Modification Service Introduction

11.5.4 Syd Labs Revenue in Peptide Modification Service Business (2020-2025)

11.5.5 Syd Labs Recent Development

11.6 JPT

11.6.1 JPT Company Details

11.6.2 JPT Business Overview

11.6.3 JPT Peptide Modification Service Introduction

11.6.4 JPT Revenue in Peptide Modification Service Business (2020-2025)

11.6.5 JPT Recent Development

11.7 LifeTein

11.7.1 LifeTein Company Details

11.7.2 LifeTein Business Overview

11.7.3 LifeTein Peptide Modification Service Introduction

11.7.4 LifeTein Revenue in Peptide Modification Service Business (2020-2025)

11.7.5 LifeTein Recent Development

11.8 Creative Peptides

11.8.1 Creative Peptides Company Details

11.8.2 Creative Peptides Business Overview

11.8.3 Creative Peptides Peptide Modification Service Introduction

11.8.4 Creative Peptides Revenue in Peptide Modification Service Business (2020-2025)

11.8.5 Creative Peptides Recent Development

11.9 Elabscience

11.9.1 Elabscience Company Details

11.9.2 Elabscience Business Overview

11.9.3 Elabscience Peptide Modification Service Introduction

11.9.4 Elabscience Revenue in Peptide Modification Service Business (2020-2025)

11.9.5 Elabscience Recent Development

11.10 Genosphere Biotechnologies

11.10.1 Genosphere Biotechnologies Company Details

11.10.2 Genosphere Biotechnologies Business Overview

11.10.3 Genosphere Biotechnologies Peptide Modification Service Introduction

11.10.4 Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2020-2025)

11.10.5 Genosphere Biotechnologies Recent Development

11.11 ProSci

11.11.1 ProSci Company Details

11.11.2 ProSci Business Overview

11.11.3 ProSci Peptide Modification Service Introduction

11.11.4 ProSci Revenue in Peptide Modification Service Business (2020-2025)

11.11.5 ProSci Recent Development

11.12 Giotto Biotech

11.12.1 Giotto Biotech Company Details

11.12.2 Giotto Biotech Business Overview

11.12.3 Giotto Biotech Peptide Modification Service Introduction

11.12.4 Giotto Biotech Revenue in Peptide Modification Service Business (2020-2025)

11.12.5 Giotto Biotech Recent Development

11.13 SB-PEPTIDE

11.13.1 SB-PEPTIDE Company Details

11.13.2 SB-PEPTIDE Business Overview

11.13.3 SB-PEPTIDE Peptide Modification Service Introduction

11.13.4 SB-PEPTIDE Revenue in Peptide Modification Service Business (2020-2025)

11.13.5 SB-PEPTIDE Recent Development

11.14 Biomatik

11.14.1 Biomatik Company Details

11.14.2 Biomatik Business Overview

11.14.3 Biomatik Peptide Modification Service Introduction

11.14.4 Biomatik Revenue in Peptide Modification Service Business (2020-2025)

11.14.5 Biomatik Recent Development

11.15 allele life sciences

11.15.1 allele life sciences Company Details

11.15.2 allele life sciences Business Overview

11.15.3 allele life sciences Peptide Modification Service Introduction

11.15.4 allele life sciences Revenue in Peptide Modification Service Business (2020-2025)

11.15.5 allele life sciences Recent Development

11.16 Synpeptide

11.16.1 Synpeptide Company Details

11.16.2 Synpeptide Business Overview

11.16.3 Synpeptide Peptide Modification Service Introduction

11.16.4 Synpeptide Revenue in Peptide Modification Service Business (2020-2025)

11.16.5 Synpeptide Recent Development

11.17 Omizzur

11.17.1 Omizzur Company Details

11.17.2 Omizzur Business Overview

11.17.3 Omizzur Peptide Modification Service Introduction

11.17.4 Omizzur Revenue in Peptide Modification Service Business (2020-2025)

11.17.5 Omizzur Recent Development

11.18 KMD Bioscience

11.18.1 KMD Bioscience Company Details

11.18.2 KMD Bioscience Business Overview

11.18.3 KMD Bioscience Peptide Modification Service Introduction

11.18.4 KMD Bioscience Revenue in Peptide Modification Service Business (2020-2025)

11.18.5 KMD Bioscience Recent Development

11.19 Leadgene Biomedical

11.19.1 Leadgene Biomedical Company Details

11.19.2 Leadgene Biomedical Business Overview

11.19.3 Leadgene Biomedical Peptide Modification Service Introduction

11.19.4 Leadgene Biomedical Revenue in Peptide Modification Service Business (2020-2025)

11.19.5 Leadgene Biomedical Recent Development

11.20 KenPeptide

11.20.1 KenPeptide Company Details

11.20.2 KenPeptide Business Overview

11.20.3 KenPeptide Peptide Modification Service Introduction

11.20.4 KenPeptide Revenue in Peptide Modification Service Business (2020-2025)

11.20.5 KenPeptide Recent Development

11.21 CASLO

11.21.1 CASLO Company Details

11.21.2 CASLO Business Overview

11.21.3 CASLO Peptide Modification Service Introduction

11.21.4 CASLO Revenue in Peptide Modification Service Business (2020-2025)

11.21.5 CASLO Recent Development

11.22 TGpeptide

11.22.1 TGpeptide Company Details

11.22.2 TGpeptide Business Overview

11.22.3 TGpeptide Peptide Modification Service Introduction

11.22.4 TGpeptide Revenue in Peptide Modification Service Business (2020-2025)

11.22.5 TGpeptide Recent Development

11.23 Boston Cellron

11.23.1 Boston Cellron Company Details

11.23.2 Boston Cellron Business Overview

11.23.3 Boston Cellron Peptide Modification Service Introduction

11.23.4 Boston Cellron Revenue in Peptide Modification Service Business (2020-2025)

11.23.5 Boston Cellron Recent Development

11.24 Bio Basic

11.24.1 Bio Basic Company Details

11.24.2 Bio Basic Business Overview

11.24.3 Bio Basic Peptide Modification Service Introduction

11.24.4 Bio Basic Revenue in Peptide Modification Service Business (2020-2025)

11.24.5 Bio Basic Recent Development

11.25 ProBioGen

11.25.1 ProBioGen Company Details

11.25.2 ProBioGen Business Overview

11.25.3 ProBioGen Peptide Modification Service Introduction

11.25.4 ProBioGen Revenue in Peptide Modification Service Business (2020-2025)

11.25.5 ProBioGen Recent Development

11.26 buchiglasuster

11.26.1 buchiglasuster Company Details

11.26.2 buchiglasuster Business Overview

11.26.3 buchiglasuster Peptide Modification Service Introduction

11.26.4 buchiglasuster Revenue in Peptide Modification Service Business (2020-2025)

11.26.5 buchiglasuster Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GenScript

Biosynth

Bio-Synthesis

Syd Labs

JPT

LifeTein

Creative Peptides

Elabscience

Genosphere Biotechnologies

ProSci

SB-PEPTIDE

Biomatik

Allele Life Sciences

Synpeptide

Omizzur

KMD Bioscience

Leadgene Biomedical

Boston Cellron

Bio Basic

Giotto Biotech

KenPeptide

CASLO

TGpeptide

Thermo Fisher Scientific

ProBioGen

Buchiglasuster

List of Tables

Table 1. Global Peptide Modification Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of N-Terminal Modifications

Table 3. Key Players of C-Terminal Modifications

Table 4. Key Players of Fluorescence Dye Labeling

Table 5. Key Players of Phosphorylation

Table 6. Key Players of Others

Table 7. Global Peptide Modification Service Market Size Growth Rate by Modification Purpose/Function (US$ Million): 2020 VS 2024 VS 2031

Table 8. Key Players of Stability Optimization (amidation, cyclization, PEGylation)

Table 9. Key Players of Targeting/Delivery (antibody conjugation, cell-penetrating peptide)

Table 10. Key Players of Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA)

Table 11. Key Players of PTM Mimicry (phosphorylation, glycosylation, methylation)

Table 12. Key Players of Immunoenhancement (KLH/BSA conjugation, MAPs)

Table 13. Global Peptide Modification Service Market Size Growth Rate by Synthesis & Process Route (US$ Million): 2020 VS 2024 VS 2031

Table 14. Key Players of Solid-phase Peptide Synthesis (SPPS)-integrated

Table 15. Key Players of Solution-phase Synthesis

Table 16. Key Players of Post-synthesis Modification

Table 17. Key Players of In-situ Modification During Synthesis

Table 18. Global Peptide Modification Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Peptide Modification Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 20. Global Peptide Modification Service Market Size by Region (2020-2025) & (US$ Million)

Table 21. Global Peptide Modification Service Market Share by Region (2020-2025)

Table 22. Global Peptide Modification Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 23. Global Peptide Modification Service Market Share by Region (2026-2031)

Table 24. Peptide Modification Service Market Trends

Table 25. Peptide Modification Service Market Drivers

Table 26. Peptide Modification Service Market Challenges

Table 27. Peptide Modification Service Market Restraints

Table 28. Global Peptide Modification Service Revenue by Players (2020-2025) & (US$ Million)

Table 29. Global Peptide Modification Service Market Share by Players (2020-2025)

Table 30. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2024)

Table 31. Ranking of Global Top Peptide Modification Service Companies by Revenue (US$ Million) in 2024

Table 32. Global 5 Largest Players Market Share by Peptide Modification Service Revenue (CR5 and HHI) & (2020-2025)

Table 33. Global Key Players of Peptide Modification Service, Headquarters and Area Served

Table 34. Global Key Players of Peptide Modification Service, Product and Application

Table 35. Global Key Players of Peptide Modification Service, Date of Enter into This Industry

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Peptide Modification Service Market Size by Type (2020-2025) & (US$ Million)

Table 38. Global Peptide Modification Service Revenue Market Share by Type (2020-2025)

Table 39. Global Peptide Modification Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 40. Global Peptide Modification Service Revenue Market Share by Type (2026-2031)

Table 41. Global Peptide Modification Service Market Size by Application (2020-2025) & (US$ Million)

Table 42. Global Peptide Modification Service Revenue Market Share by Application (2020-2025)

Table 43. Global Peptide Modification Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 44. Global Peptide Modification Service Revenue Market Share by Application (2026-2031)

Table 45. North America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. North America Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)

Table 47. North America Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)

Table 48. Europe Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Europe Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)

Table 50. Europe Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)

Table 51. Asia-Pacific Peptide Modification Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 52. Asia-Pacific Peptide Modification Service Market Size by Region (2020-2025) & (US$ Million)

Table 53. Asia-Pacific Peptide Modification Service Market Size by Region (2026-2031) & (US$ Million)

Table 54. Latin America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 55. Latin America Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)

Table 56. Latin America Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)

Table 57. Middle East & Africa Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 58. Middle East & Africa Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)

Table 59. Middle East & Africa Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)

Table 60. GenScript Company Details

Table 61. GenScript Business Overview

Table 62. GenScript Peptide Modification Service Product

Table 63. GenScript Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 64. GenScript Recent Development

Table 65. Biosynth Company Details

Table 66. Biosynth Business Overview

Table 67. Biosynth Peptide Modification Service Product

Table 68. Biosynth Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 69. Biosynth Recent Development

Table 70. Bio-Synthesis Company Details

Table 71. Bio-Synthesis Business Overview

Table 72. Bio-Synthesis Peptide Modification Service Product

Table 73. Bio-Synthesis Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 74. Bio-Synthesis Recent Development

Table 75. Thermo Fisher Scientific Company Details

Table 76. Thermo Fisher Scientific Business Overview

Table 77. Thermo Fisher Scientific Peptide Modification Service Product

Table 78. Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 79. Thermo Fisher Scientific Recent Development

Table 80. Syd Labs Company Details

Table 81. Syd Labs Business Overview

Table 82. Syd Labs Peptide Modification Service Product

Table 83. Syd Labs Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 84. Syd Labs Recent Development

Table 85. JPT Company Details

Table 86. JPT Business Overview

Table 87. JPT Peptide Modification Service Product

Table 88. JPT Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 89. JPT Recent Development

Table 90. LifeTein Company Details

Table 91. LifeTein Business Overview

Table 92. LifeTein Peptide Modification Service Product

Table 93. LifeTein Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 94. LifeTein Recent Development

Table 95. Creative Peptides Company Details

Table 96. Creative Peptides Business Overview

Table 97. Creative Peptides Peptide Modification Service Product

Table 98. Creative Peptides Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 99. Creative Peptides Recent Development

Table 100. Elabscience Company Details

Table 101. Elabscience Business Overview

Table 102. Elabscience Peptide Modification Service Product

Table 103. Elabscience Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 104. Elabscience Recent Development

Table 105. Genosphere Biotechnologies Company Details

Table 106. Genosphere Biotechnologies Business Overview

Table 107. Genosphere Biotechnologies Peptide Modification Service Product

Table 108. Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 109. Genosphere Biotechnologies Recent Development

Table 110. ProSci Company Details

Table 111. ProSci Business Overview

Table 112. ProSci Peptide Modification Service Product

Table 113. ProSci Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 114. ProSci Recent Development

Table 115. Giotto Biotech Company Details

Table 116. Giotto Biotech Business Overview

Table 117. Giotto Biotech Peptide Modification Service Product

Table 118. Giotto Biotech Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 119. Giotto Biotech Recent Development

Table 120. SB-PEPTIDE Company Details

Table 121. SB-PEPTIDE Business Overview

Table 122. SB-PEPTIDE Peptide Modification Service Product

Table 123. SB-PEPTIDE Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 124. SB-PEPTIDE Recent Development

Table 125. Biomatik Company Details

Table 126. Biomatik Business Overview

Table 127. Biomatik Peptide Modification Service Product

Table 128. Biomatik Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 129. Biomatik Recent Development

Table 130. allele life sciences Company Details

Table 131. allele life sciences Business Overview

Table 132. allele life sciences Peptide Modification Service Product

Table 133. allele life sciences Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 134. allele life sciences Recent Development

Table 135. Synpeptide Company Details

Table 136. Synpeptide Business Overview

Table 137. Synpeptide Peptide Modification Service Product

Table 138. Synpeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 139. Synpeptide Recent Development

Table 140. Omizzur Company Details

Table 141. Omizzur Business Overview

Table 142. Omizzur Peptide Modification Service Product

Table 143. Omizzur Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 144. Omizzur Recent Development

Table 145. KMD Bioscience Company Details

Table 146. KMD Bioscience Business Overview

Table 147. KMD Bioscience Peptide Modification Service Product

Table 148. KMD Bioscience Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 149. KMD Bioscience Recent Development

Table 150. Leadgene Biomedical Company Details

Table 151. Leadgene Biomedical Business Overview

Table 152. Leadgene Biomedical Peptide Modification Service Product

Table 153. Leadgene Biomedical Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 154. Leadgene Biomedical Recent Development

Table 155. KenPeptide Company Details

Table 156. KenPeptide Business Overview

Table 157. KenPeptide Peptide Modification Service Product

Table 158. KenPeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 159. KenPeptide Recent Development

Table 160. CASLO Company Details

Table 161. CASLO Business Overview

Table 162. CASLO Peptide Modification Service Product

Table 163. CASLO Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 164. CASLO Recent Development

Table 165. TGpeptide Company Details

Table 166. TGpeptide Business Overview

Table 167. TGpeptide Peptide Modification Service Product

Table 168. TGpeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 169. TGpeptide Recent Development

Table 170. Boston Cellron Company Details

Table 171. Boston Cellron Business Overview

Table 172. Boston Cellron Peptide Modification Service Product

Table 173. Boston Cellron Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 174. Boston Cellron Recent Development

Table 175. Bio Basic Company Details

Table 176. Bio Basic Business Overview

Table 177. Bio Basic Peptide Modification Service Product

Table 178. Bio Basic Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 179. Bio Basic Recent Development

Table 180. ProBioGen Company Details

Table 181. ProBioGen Business Overview

Table 182. ProBioGen Peptide Modification Service Product

Table 183. ProBioGen Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 184. ProBioGen Recent Development

Table 185. buchiglasuster Company Details

Table 186. buchiglasuster Business Overview

Table 187. buchiglasuster Peptide Modification Service Product

Table 188. buchiglasuster Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)

Table 189. buchiglasuster Recent Development

Table 190. Research Programs/Design for This Report

Table 191. Key Data Information from Secondary Sources

Table 192. Key Data Information from Primary Sources

Table 193. Authors List of This Report

List of Figures

Figure 1. Peptide Modification Service Picture

Figure 2. Global Peptide Modification Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide Modification Service Market Share by Type: 2024 VS 2031

Figure 4. N-Terminal Modifications Features

Figure 5. C-Terminal Modifications Features

Figure 6. Fluorescence Dye Labeling Features

Figure 7. Phosphorylation Features

Figure 8. Others Features

Figure 9. Global Peptide Modification Service Market Size Comparison by Modification Purpose/Function (2020-2031) & (US$ Million)

Figure 10. Stability Optimization (amidation, cyclization, PEGylation) Features

Figure 11. Targeting/Delivery (antibody conjugation, cell-penetrating peptide) Features

Figure 12. Detection/Labeling (FITC, Cy3/Cy5, biotin, DOTA) Features

Figure 13. PTM Mimicry (phosphorylation, glycosylation, methylation) Features

Figure 14. Immunoenhancement (KLH/BSA conjugation, MAPs) Features

Figure 15. Global Peptide Modification Service Market Size Comparison by Synthesis & Process Route (2020-2031) & (US$ Million)

Figure 16. Solid-phase Peptide Synthesis (SPPS)-integrated Features

Figure 17. Solution-phase Synthesis Features

Figure 18. Post-synthesis Modification Features

Figure 19. In-situ Modification During Synthesis Features

Figure 20. Global Peptide Modification Service Market Size by Application (2020-2031) & (US$ Million)

Figure 21. Global Peptide Modification Service Market Share by Application: 2024 VS 2031

Figure 22. Commercial Case Studies

Figure 23. Academic Research Case Studies

Figure 24. Peptide Modification Service Report Years Considered

Figure 25. Global Peptide Modification Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 26. Global Peptide Modification Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 27. Global Peptide Modification Service Market Share by Region: 2024 VS 2031

Figure 28. Global Peptide Modification Service Market Share by Players in 2024

Figure 29. Global Peptide Modification Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 30. The Top 10 and 5 Players Market Share by Peptide Modification Service Revenue in 2024

Figure 31. North America Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. North America Peptide Modification Service Market Share by Country (2020-2031)

Figure 33. United States Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Canada Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Europe Peptide Modification Service Market Share by Country (2020-2031)

Figure 37. Germany Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. France Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. U.K. Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Italy Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Russia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Ireland Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Peptide Modification Service Market Share by Region (2020-2031)

Figure 45. China Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Japan Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. South Korea Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. India Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Australia & New Zealand Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Latin America Peptide Modification Service Market Share by Country (2020-2031)

Figure 53. Mexico Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Brazil Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Middle East & Africa Peptide Modification Service Market Share by Country (2020-2031)

Figure 57. Israel Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. UAE Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. GenScript Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 61. Biosynth Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 62. Bio-Synthesis Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 64. Syd Labs Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 65. JPT Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 66. LifeTein Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 67. Creative Peptides Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 68. Elabscience Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 69. Genosphere Biotechnologies Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 70. ProSci Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 71. Giotto Biotech Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 72. SB-PEPTIDE Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 73. Biomatik Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 74. allele life sciences Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 75. Synpeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 76. Omizzur Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 77. KMD Bioscience Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 78. Leadgene Biomedical Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 79. KenPeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 80. CASLO Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 81. TGpeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 82. Boston Cellron Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 83. Bio Basic Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 84. ProBioGen Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 85. buchiglasuster Revenue Growth Rate in Peptide Modification Service Business (2020-2025)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Standard Peptide Custom Synthesis Service Market Research Report 2024

Global Long Chain Modified Peptide Drugs Market Research Report 2024

Global Peptide API Market Research Report 2024

High Quality Custom Peptide Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Analysis Market Research Report 2025

Global Modified Peptide Synthesis Services Market Research Report 2025

Global Cyclic Peptide Compounds Market Research Report 2024

Global GMP Grade Peptide Market Research Report 2024

Global Peptide Microarray Assay Service Market Research Report 2025

Global Oral Peptide Therapeutics Market Research Report 2024

Global Peptide Antibiotics Market Research Report 2025

Global Peptide Purification System Market Research Report 2024

Global Cosmetic Peptide Manufacturing Market Research Report 2024

Global Silk Peptide Market Research Report 2024

Global High Pure Peptides Market Research Report 2025

Global Endogenous Peptide Substances Market Research Report 2024

Catalog Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ovalbumin Peptide Market Research Report 2024

Global Cosmetic Peptides Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions